The virtual assay software for human in silico drug trials to augment drug cardiac testing

The virtual assay software for human in silico drug trials to augment drug cardiac testing

Prediction of drug effects on the heart still represents a challenge in drug development, given potential adverse outcomes. Computer modelling and simulations of the human heart offer a powerful technology to augment existing animal and clinical methodologies. Here we describe the translation proces...

Полное описание

Библиографические подробности
Главные авторы:	Passini, E, Zhou, X, Trovato, C, Britton, OJ, Bueno-Orovio, A, Rodriguez, B
Формат:	Journal article
Язык:	English
Опубликовано:	Elsevier 2020

Схожие документы

Drug‐induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias
по: Passini, E, и др.
Опубликовано: (2019)

Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment
по: Zhou, X, и др.
Опубликовано: (2020)

Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction
по: Cristian Trovato, и др.
Опубликовано: (2022-10-01)

Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity
по: Passini, E, и др.
Опубликовано: (2017)

P511 In silico trials in human ventricular and purkinje cell models predict safety and efficacy of 10 antiarrhythmic drugs
по: Trovato, C, и др.
Опубликовано: (2017)

Variability in cardiac electrophysiology: Using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm.
по: Muszkiewicz, A, и др.
Опубликовано: (2015)

In-silico drug trials for precision medicine in atrial fibrillation: from ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
по: Dasí, A, и др.
Опубликовано: (2022)

In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
по: Albert Dasí, и др.
Опубликовано: (2022-09-01)

In silico evaluation of arrhythmia
по: Zhou, X, и др.
Опубликовано: (2017)

What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
по: Dasí, A, и др.
Опубликовано: (2023)

Is it time for in silico simulation of drug cardiac side effects?
по: Mirams, G, и др.
Опубликовано: (2011)

Is it time for in silico simulation of drug cardiac side effects?
по: Mirams, G, и др.
Опубликовано: (2011)

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
по: Tomek, J, и др.
Опубликовано: (2019)

In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment
по: Margara, F, и др.
Опубликовано: (2020)

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
по: Jakub Tomek, и др.
Опубликовано: (2019-12-01)

Virtual and Augmented Reality in Cardiac Surgery
по: Arian Arjomandi Rad, и др.
Опубликовано: (2021-12-01)

Toward a broader view of mechanisms of drug cardiotoxicity
по: Mamoshina, P, и др.
Опубликовано: (2021)

In vitro Assays and Imaging Methods for Drug Discovery for Cardiac Fibrosis
по: Giorgia Palano, и др.
Опубликовано: (2021-07-01)

Natural Lipid Extracts as an Artificial Membrane for Drug Permeability Assay: In Vitro and In Silico Characterization
по: Anna Vincze, и др.
Опубликовано: (2023-03-01)

VirtualToxLab – in silico Prediction of the Endocrine-Disrupting Potential of Drugs and Chemicals
по: Angelo Vedani, и др.
Опубликовано: (2008-05-01)

All-optical electrophysiology refines populations of in silico human iPSC-CMs for drug evaluation
по: Paci, M, и др.
Опубликовано: (2020)

Potential Drug-Drug Interactions in a Cardiac Center: Development of Simple Software for Pattern Identification
по: Fatemeh Rangraz Jeddi, и др.
Опубликовано: (2022-10-01)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
по: Eric March-Vila, и др.
Опубликовано: (2017-05-01)

Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity
по: Mamoshina, P, и др.
Опубликовано: (2020)

The STEM teachers' course "Development of virtual and augmented reality software"
по: Mykhailo Mintii
Опубликовано: (2021-09-01)

Drug susceptibility testing of Mycobacterium tuberculosis using next generation sequencing and Mykrobe software
по: V. Tolchkov, и др.
Опубликовано: (2022-01-01)

Human ventricular modelling and simulation of drug action on electrophysiology and contraction
по: Margara, F, и др.
Опубликовано: (2021)

Cheburator software for automatically calculating drug inhibitory concentrations from in vitro screening assays.
по: Dmitry Nevozhay
Опубликовано: (2014-01-01)

Enhanced drug classification using machine learning with multiplexed cardiac contractility assays
по: Reza Aghavali, и др.
Опубликовано: (2024-11-01)

Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation
по: Muhammad Adnan Pramudito, и др.
Опубликовано: (2024-10-01)

A new classifier-based strategy for in-silico ion-channel cardiac drug safety assessment
по: Hitesh eMistry, и др.
Опубликовано: (2015-03-01)

The importance of in-silico studies in drug discovery
по: Roney, Miah, и др.
Опубликовано: (2024)

A Guide to In Silico Drug Design
по: Yiqun Chang, и др.
Опубликовано: (2022-12-01)

An integrated dataset for in silico drug discovery
по: Cockell Simon J, и др.
Опубликовано: (2010-12-01)

SMOD - data augmentation based on statistical models of deformation to enhance segmentation in 2D cine cardiac MRI
по: Corral Acero, J, и др.
Опубликовано: (2019)

Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight
по: Giang H. Ta, и др.
Опубликовано: (2024-11-01)

In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
по: Adrián César-Razquin, и др.
Опубликовано: (2018-09-01)

Comparison of the simulated response of three in silico human stem cell-derived cardiomyocytes models and in vitro data under 15 drug actions
по: Paci, M, и др.
Опубликовано: (2021)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
по: Doste, R, и др.
Опубликовано: (2021)

Multiscale Modelling of β-Adrenergic Stimulation in Cardiac Electromechanical Function
по: Ruben Doste, и др.
Опубликовано: (2021-07-01)